Sign Up Today and Learn More About Triana Biomedicines Stock
Invest in or calculate the value of your shares in Triana Biomedicines or other pre-IPO companies through EquityZen's platform.
Triana Biomedicines Stock
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
About Triana Biomedicines Stock
Founded
2019
Headquarters
Lexington, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Triana Biomedicines Press Mentions
Stay in the know about the latest news on Triana Biomedicines
TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
biospace • May 19, 2026
TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
businesswire • May 18, 2026
TRIANA Biomedicines Announces the Appointment of Mohan Bala as Chief Operating Officer and Attracts Leading Experts to its Scientific Advisory Board
pharmiweb • May 18, 2026
TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026
businesswire • Apr 16, 2026
TRIANA Biomedicines Announces Oral Presentation of TRI-611 and Additional Poster Presentations at the American Association for Cancer Research Annual Meeting 2026
biospace • Apr 15, 2026
Triana Biomedicines Management
Leadership team at Triana Biomedicines
Board Member
Andrew Hedin
Board Member
Milind Deshpande
Join now and verify your accreditation status to gain access to:
- Triana Biomedicines Current Valuation
- Triana Biomedicines Stock Price
- Triana Biomedicines Management
- Available deals in Triana Biomedicines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Triana Biomedicines Cap Table and Funding History by Share Class and Liquidity Preferences
- Triana Biomedicines Revenue and Financials
- Triana Biomedicines Highlights
- Triana Biomedicines Business Model
- Triana Biomedicines Risk Factors
- Triana Biomedicines Research Report from SACRA Research
Trading Triana Biomedicines Stock
How to invest in Triana Biomedicines stock?
Accredited investors can buy pre-IPO stock in companies like Triana Biomedicines through EquityZen funds. These investments are made available by existing Triana Biomedicines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Triana Biomedicines stock?
Shareholders can sell their Triana Biomedicines stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."